000 | 01533 a2200445 4500 | ||
---|---|---|---|
005 | 20250514023749.0 | ||
264 | 0 | _c20020422 | |
008 | 200204s 0 0 eng d | ||
022 | _a0014-3022 | ||
024 | 7 |
_a10.1159/000047962 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHwang, Wen-Jun | |
245 | 0 | 0 |
_aDownregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation. _h[electronic resource] |
260 |
_bEuropean neurology _c2002 |
||
300 |
_a113-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBenzamides |
650 | 0 | 4 |
_aCorpus Striatum _xdiagnostic imaging |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIodine Radioisotopes |
650 | 0 | 4 |
_aLevodopa _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMotor Skills _xdrug effects |
650 | 0 | 4 |
_aNeurologic Examination _xdrug effects |
650 | 0 | 4 |
_aParkinson Disease _xdiagnostic imaging |
650 | 0 | 4 | _aPyrrolidines |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xdrug effects |
650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
700 | 1 | _aYao, Wei-Jen | |
700 | 1 | _aWey, Shiaw-Pyng | |
700 | 1 | _aShen, Lie-Hang | |
700 | 1 | _aTing, Gann | |
773 | 0 |
_tEuropean neurology _gvol. 47 _gno. 2 _gp. 113-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000047962 _zAvailable from publisher's website |
999 |
_c11753565 _d11753565 |